SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?


To: Phil who wrote (1282)8/19/1999 2:56:00 AM
From: Bruce Byall  Read Replies (1) | Respond to of 1754
 
LVCI uses VISX. Good earnings and ( IMHO ) excellent CC.

Conference call can be heard at:

corporate-ir.net

LaserVision Posts $0.14 Per Share Profit For First Quarter; Gross Profit Increases 151%; Revenue Up 131%

ST. LOUIS--(BW HealthWire)--Aug. 18, 1999--LASER VISION CENTERS,
INC., (Nasdaq: LVCI) announced today that revenue for its first
quarter ended July 31, 1999, was $20,999,000 compared to $9,110,000
for the same period a year ago.

Net income for the quarter was $4,133,000 or $0.17 per share

To: MGV who wrote (265)
From: Robert G. Harrell

Wednesday, Aug 18 1999 5:34PM ET
Reply # of 268

I just caught the last 20-25 minutes of the CC. The sell off today was apparently caused by misunderstanding of the pricing structure. LVCI gets approximately $700 per procedure regardless of what the surgeon charges. A price war between surgeons would only help LVCI if the lower charges produced more procedures. The sell off today was totally unwarranted. Glad I increased my holdings by 50% near the low. Will try to grab some more VISX cheap at the open tomorrow if it doesn't gap up. The sell off in VISX made even less sense.

Bob